MTVA · MetaVia Inc. Common Stock
View on chartInsiders & Stakes
| DONG-A ST CO., LTD | ▲ Buy | Open Market | 9,995,679 Shares held | 5/8/2025 | View profile |
| E&Investment, Inc. 10% Owner | ▼ Sell | Other | 2,890,533 Shares held | 7/26/2022 | View profile |
| Na Yeon Kim Director | ▲ Buy | Grant | 101,459 Shares held | 7/27/2023 | View profile |
| Hyung Heon Kim CEO & President | ▲ Buy | Grant | 37,545 Shares held | 1/23/2026 | View profile |
| Marshall H. Woodworth Chief Financial Officer | ▲ Buy | Grant | 30,734 Shares held | 1/23/2026 | View profile |
| Andrew I. Koven Director | ▲ Buy | Grant | 21,339 Shares held | 6/8/2026 | View profile |
| D. Gordon Strickland Director | ▲ Buy | Grant | 21,339 Shares held | 6/8/2026 | View profile |
| Michael Salsbury Director | ▲ Buy | Grant | 21,338 Shares held | 6/8/2026 | View profile |
| Jason L. Groves Director | ▲ Buy | Grant | 21,338 Shares held | 6/8/2026 | View profile |
| Mark A. Glickman Co-Chief Executive Officer | ▲ Buy | Grant | 20,629 Shares held | 6/8/2026 | View profile |
| James Patrick Tursi Director | ▲ Buy | Grant | 20,568 Shares held | 6/8/2026 | View profile |
Transaction History
| James Patrick Tursi | ▲ Buy | Grant | 17,186 | $0 | 6/8/2026 |
| D. Gordon Strickland | ▲ Buy | Grant | 17,186 | $0 | 6/8/2026 |
| Michael Salsbury | ▲ Buy | Grant | 17,186 | $0 | 6/8/2026 |
| Jason L. Groves | ▲ Buy | Grant | 17,186 | $0 | 6/8/2026 |
| Andrew I. Koven | ▲ Buy | Grant | 17,186 | $0 | 6/8/2026 |
| Mark A. Glickman | ▲ Buy | Grant | 17,186 | $0 | 6/8/2026 |
| Marshall H. Woodworth | ▲ Buy | Grant | 28,000 | $0 | 1/23/2026 |
| Hyung Heon Kim | ▲ Buy | Grant | 32,000 | $0 | 1/23/2026 |
| Marshall H. Woodworth | ▼ Sell | Gift | 14,200 | $0 | 8/12/2025 |
| Michael Salsbury | ▲ Buy | Grant | 28,147 | $0 | 6/30/2025 |
| Mark A. Glickman | ▲ Buy | Grant | 28,147 | $0 | 6/30/2025 |
| Jason L. Groves | ▲ Buy | Grant | 28,147 | $0 | 6/30/2025 |
| James Patrick Tursi | ▲ Buy | Grant | 28,147 | $0 | 6/30/2025 |
| D. Gordon Strickland | ▲ Buy | Grant | 28,147 | $0 | 6/30/2025 |
| Andrew I. Koven | ▲ Buy | Grant | 28,147 | $0 | 6/30/2025 |
| Marshall H. Woodworth | ▲ Buy | Open Market | 14,200 | $10K | 6/4/2025 |
| DONG-A ST CO., LTD | ▲ Buy | Open Market | 4,647,887 | $3.3M | 5/8/2025 |
| Marshall H. Woodworth | ▼ Sell | Tax Withholding | 3,417 | $5K | 3/1/2025 |
| Hyung Heon Kim | ▼ Sell | Tax Withholding | 2,795 | $4K | 3/1/2025 |
| Hyung Heon Kim | ▼ Sell | Tax Withholding | 2,867 | $7K | 11/30/2024 |
| DONG-A ST CO., LTD | ▼ Sell | Open Market | 407 | $2K | 9/12/2024 |
| Hyung Heon Kim | ▼ Sell | Tax Withholding | 11,467 | $41K | 8/11/2024 |
| DONG-A ST CO., LTD | ▲ Buy | Open Market | 2,544,530 | $8.0M | 6/23/2024 |
| Jason L. Groves | ▲ Buy | Grant | 5,051 | $0 | 6/7/2024 |
| Andrew I. Koven | ▲ Buy | Grant | 5,051 | $0 | 6/7/2024 |
| Mark A. Glickman | ▲ Buy | Grant | 5,051 | $0 | 6/7/2024 |
| D. Gordon Strickland | ▲ Buy | Grant | 5,051 | $0 | 6/7/2024 |
| Michael Salsbury | ▲ Buy | Grant | 5,051 | $0 | 6/7/2024 |
| James Patrick Tursi | ▲ Buy | Grant | 5,051 | $0 | 6/7/2024 |
| Marshall H. Woodworth | ▲ Buy | Grant | 33,496 | $0 | 3/1/2024 |
| James Patrick Tursi | ▲ Buy | Grant | 25,000 | $0 | 12/1/2023 |
| James Patrick Tursi | ▲ Buy | Grant | 7,157 | $0 | 12/1/2023 |
| Hyung Heon Kim | ▲ Buy | Grant | 625,064 | $0 | 8/11/2023 |
| Michael Salsbury | ▲ Buy | Grant | 87,500 | $0 | 7/27/2023 |
| Michael Salsbury | ▲ Buy | Grant | 12,500 | $0 | 7/27/2023 |
| D. Gordon Strickland | ▲ Buy | Grant | 87,500 | $0 | 7/27/2023 |
| D. Gordon Strickland | ▲ Buy | Grant | 12,500 | $0 | 7/27/2023 |
| Jason L. Groves | ▲ Buy | Grant | 87,500 | $0 | 7/27/2023 |
| Jason L. Groves | ▲ Buy | Grant | 12,500 | $0 | 7/27/2023 |
| Mark A. Glickman | ▲ Buy | Grant | 25,000 | $0 | 7/27/2023 |
| Mark A. Glickman | ▲ Buy | Grant | 12,500 | $0 | 7/27/2023 |
| Na Yeon Kim | ▲ Buy | Grant | 87,500 | $0 | 7/27/2023 |
| Na Yeon Kim | ▲ Buy | Grant | 12,500 | $0 | 7/27/2023 |
| Andrew I. Koven | ▲ Buy | Grant | 87,500 | $0 | 7/27/2023 |
| Andrew I. Koven | ▲ Buy | Grant | 12,500 | $0 | 7/27/2023 |
| E&Investment, Inc. | ▼ Sell | Other | 1,445,267 | $0 | 7/26/2022 |
| Na Yeon Kim | ▼ Sell | Other | 1,445,267 | $0 | 7/26/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
MTVA appoints Dr. Sarah Browne as Chief Medical Officer
MetaVia announced the appointment of Dr. Sarah Browne, M.D., as its new chief medical officer. Dr. Browne brings extensive clinical development experience, which could support the company's ongoing drug development efforts. The move comes as the stock is trading near its $1.41 support level, a point that has been tested many times.
MTVA appoints Dr. Sarah Browne as Chief Medical Officer. MetaVia announced the appointment of Dr. Sarah Browne, M.D., as its new chief medical officer. Dr. Browne brings extensive clinical development experience, which could support the company's ongoing drug development efforts. The move comes as the stock is trading near its $1.41 support level, a point that has been tested many times.